Updated:
University of Maryland Baltimore Foundation
The University of Maryland Baltimore Foundation was established in 2000 as a 501(c)(3) to receive and manage tax-deductible gifts supporting UMB's schools of...
University of Maryland Baltimore Foundation
The University of Maryland Baltimore Foundation was established in 2000 as a 501(c)(3) to receive and manage tax-deductible gifts supporting UMB's schools of medicine, law, dentistry, pharmacy, nursing, and social work. James L. Hughes serves as president alongside a board chaired by developer Brian J. Gibbons and vice-chaired by pharmacy executive Ellen H. Yankellow, embedding private-sector real-estate and healthcare-operating experience into the governance of an affiliated foundation that pools its endowment with the University System of Maryland Foundation. UMBF's investment posture fuses pooled endowment exposure with direct real-asset development. Its most visible deployment is the University of Maryland BioPark, a 14-acre mixed-use innovation district in West Baltimore developed with Wexford Science + Technology that houses life-sciences tenants and the Maryland Proton Treatment Center. The foundation's balance sheet extends to commercial holdings including 220 Arch Street, 800 West Baltimore Street, and the Lion Brothers Building, while its venture exposure runs through UM Ventures — a technology-transfer partnership with the University of Maryland, College Park that commercializes faculty research. The BioPark was named AURP Research Park of the Year in 2017 (per the Association for University Research Parks). UMBF's leadership circles include the Solomon Society and the Circle of Red, donor-engagement vehicles that channel individual philanthropy into the foundation's endowment corpus. Trustee Barry Garber founded the Solomon Society as a men's giving circle; trustee Ellen Yankellow convened the Circle of Red around women's cardiovascular philanthropy. Luke Cooper, founder of Latimer Ventures, also serves on the board. In 2017, the BioPark earned national recognition from the Association for University Research Parks as Research Park of the Year. The foundation's structural differentiator is its dual role as both a pooled endowment investor and a direct real-estate developer on behalf of a public health-sciences university. Unlike most university-affiliated foundations that outsource property management, UMBF stewards an in-house portfolio of commercial and mixed-use assets adjacent to campus, using that proximity to attract biomedical tenants whose leases generate returns while advancing UMB's research mission.
General information
Firm type
Endowment / Foundation
Year founded
2000
Location
Region
North America
Country
United States
City
Baltimore
Corporate office
Baltimore, MD, United States
Principals
James L. Hughes
President
Brian J. Gibbons
Chair of the Board of Trustees
Ellen H. Yankellow
Vice Chair of the Board of Trustees
Sector focus
Frequently asked questions
How is UMBF's endowment managed?
UMBF pools its endowment assets with the University System of Maryland Foundation, which provides centralized investment management across all USM-affiliated institutions. UMBF's board retains governance over gift acceptance and donor-intent compliance, while the USM Foundation handles day-to-day portfolio allocation and manager selection.
What is the University of Maryland BioPark?
The BioPark is a 14-acre mixed-use research park developed by UMBF in partnership with Wexford Science + Technology on Baltimore's west side. It houses life-sciences companies, university research facilities, and the Maryland Proton Treatment Center. The Association for University Research Parks named it Research Park of the Year in 2017.
Does UMBF make direct venture investments?
UMBF gains venture exposure primarily through UM Ventures, a technology-transfer collaboration with the University of Maryland, College Park that commercializes faculty research and spins out startups. The foundation does not operate a standalone venture fund or make direct venture investments independent of UM Ventures.
Who are the key decision-makers at the foundation?
James L. Hughes serves as president of UMBF and is also UMB's Chief Enterprise and Economic Development Officer. Brian J. Gibbons chairs the board of trustees — he is CEO of Greenberg Gibbons, a regional commercial developer — and Ellen H. Yankellow serves as vice chair. Luke Cooper, CEO of Latimer Ventures, also sits on the board.
What is the foundation's relationship to the University System of Maryland?
UMBF is an affiliated foundation of the University System of Maryland, meaning it operates as a legally separate nonprofit that exclusively supports UMB. It pools its endowment with the USM Foundation for investment purposes but maintains its own board and gift-governance authority.
What real estate assets does UMBF own?
Known commercial and mixed-use holdings include the University of Maryland BioPark, 220 Arch Street, the Lion Brothers Building at 875 Hollins Street, 800 West Baltimore Street, 4MLK on MLK Boulevard, and the Maryland Proton Treatment Center. The foundation also stewards Davidge Hall on West Lombard Street and the Donaldson Brown Riverfront Event Center in Port Deposit.
How significant is donor-directed philanthropy to UMBF's capital base?
Gift management is UMBF's primary function — tax-deductible contributions flow through the foundation's operating and endowment funds with strict adherence to donor intent. The foundation cultivates donor communities through the Legacy Council for planned-giving donors, the Solomon Society for men's leadership philanthropy founded by Barry Garber, and the Circle of Red for women's cardiovascular giving founded by Ellen Yankellow.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: